These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effect of donor treatment with heterologous antilymphocyte globulin on kidney homograft survival. Cerilli J; Groth C; Taylor P; Daloze P Transplantation; 1967 Sep; 5(5):1334-5. PubMed ID: 4168159 [No Abstract] [Full Text] [Related]
6. Non-specific and adaptive immunity in renal transplantation. Alexander JW; McCoy HV; Phair JP; Altemeier WA Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227 [No Abstract] [Full Text] [Related]
7. The pathophysiology of renal allograft rejection: a collective review. Balch CM; Diethelm AG J Surg Res; 1972 May; 12(5):350-77. PubMed ID: 4554836 [No Abstract] [Full Text] [Related]
8. Mechanisms of immunological injury during antibody-mediated hyperacute rejection of renal heterografts. Rosenberg JC; Hawkins E; Rector F Transplantation; 1971 Feb; 11(2):151-7. PubMed ID: 4931239 [No Abstract] [Full Text] [Related]
9. [Humoral immunity factors in clinical kidney transplantation]. Shkurko VI; Zaretskaia IuM; Slov'ev GM; Sochnev AM Klin Med (Mosk); 1973 Jun; 51(6):98-104. PubMed ID: 4590260 [No Abstract] [Full Text] [Related]
10. Immunobiological diagnosis of rejection in dogs with renal allografts. Häyry P; Lindström BL; Virolainen M; Pasternack A; Lindfors O Surgery; 1972 Apr; 71(4):494-506. PubMed ID: 4553656 [No Abstract] [Full Text] [Related]
11. Transfer factor, homograft rejection and the effects of antilymphocyte serum in man. Lawrence HS Fed Proc; 1970; 29(1):183-5. PubMed ID: 4904622 [No Abstract] [Full Text] [Related]
12. Pathology of canine renal allografts prolonged by sheep antilymphocyte plasma. Fox M; Diethelm AG; Glassock RJ; Orr WM; Dubernard JM; Stuart FP; Dammin GJ; Murray JE Invest Urol; 1971 Mar; 8(5):563-74. PubMed ID: 4104119 [No Abstract] [Full Text] [Related]
13. [Prolongation of allograft survival in mice by transplantation antigens incubated with normal serum. 1. Identification of the active serum fraction]. Elie R; Liabeuf A; Lamoureux G Ann Immunol (Paris); 1973 Nov; 124(4):539-54. PubMed ID: 4134957 [No Abstract] [Full Text] [Related]
14. Mechanism for prolonged survival of pig renal allografts. Perper RJ; Bowersox BE; Van Gorder TJ Transplantation; 1971 Jun; 11(6):505-13. PubMed ID: 4931451 [No Abstract] [Full Text] [Related]
15. DEAE-cellulose batch production of immunoglobulin G (IgG) from antilymphocyte serum (ALS). Mogi G; Harvey JE; Ogura JH Laryngoscope; 1972 Jun; 82(6):998-1006. PubMed ID: 4113861 [No Abstract] [Full Text] [Related]
16. Pathology of human renal allograft rejection. Deodhar SD; Benjamin SP Surg Clin North Am; 1971 Oct; 51(5):1141-59. PubMed ID: 4938648 [No Abstract] [Full Text] [Related]
18. In vitro demonstration of suppression of the efferent site in transplantation immunity with antilymphocyte serum. Tadakuma T; Watanabe S; Mitsuma T; Saito K Jpn J Microbiol; 1971 Jan; 15(1):105-8. PubMed ID: 4927837 [No Abstract] [Full Text] [Related]
19. The participation of platelets in the rejection of dog kidney allotransplants: hematologic and electron microscopic studies. Lowenhaupt R; Nathan P Transplant Proc; 1969 Mar; 1(1):305-10. PubMed ID: 4944232 [No Abstract] [Full Text] [Related]
20. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow. Caridis DT; Liegeois A; Barrett I; Monaco AP Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126 [No Abstract] [Full Text] [Related] [Next] [New Search]